Spiro Rombotis
2018
In 2018, Spiro Rombotis earned a total compensation of $752.8K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $119,772 |
|---|---|
| Option Awards | $69,834 |
| Salary | $530,553 |
| Other | $32,665 |
| Total | $752,824 |
Rombotis received $530.6K in salary, accounting for 70% of the total pay in 2018.
Rombotis also received $119.8K in bonus, $69.8K in option awards and $32.7K in other compensation.
Rankings
In 2018, Spiro Rombotis' compensation ranked 10,429th out of 14,244 executives tracked by ExecPay. In other words, Rombotis earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,429 out of 14,244 | 27th |
Division Manufacturing | 4,204 out of 5,762 | 27th |
Major group Chemicals And Allied Products | 1,580 out of 2,125 | 26th |
Industry group Drugs | 1,334 out of 1,814 | 27th |
Industry Pharmaceutical Preparations | 1,026 out of 1,388 | 26th |
Source: SEC filing on May 12, 2020.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2018.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020